C-746CNeuroVision Imaging
retinal imaging, blood biomarkers, telehealth
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-746C
C-746CC-746Cretinal imaging, blood biomarkers, telehealth
0-100 chain-logic scale · 15 dimensions · scored on public evidence
NeuroVision Imaging retinal imaging, blood biomarkers, telehealth
NeuroVision Imaging is developing an integrated BrainHealth Platform for earlier detection and longitudinal care in neurodegenerative disease. Its platforms include BrainHealth Clinic for telehealth cognitive care, Afina retinal imaging, and Duritect blood biomarker diagnostics acquired from Durin Life Sciences. The company focuses on making early diagnosis routine, actionable, and accessible across primary care, biomarker testing, imaging, neurology access, and ongoing management.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
NeuroVision Imaging — Far from goals · Lower middle. Derived deterministically from 5 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (3 programs at undisclosed).…
Source: Deterministic